世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

モバイル医療とホームモニタリング (第9版)

mHealth and Home Monitoring – 9th Edition

 

出版社 出版年月冊子体価格電子版価格 ページ数
Berg Insight
ベルグインサイト社
2018年12月Eur1,200Eur1,800
1-5ユーザライセンス(PDF)
300

サマリー

スウェーデンの調査会社ベルグインサイト社(Berg Insight)の調査レポート「モバイル医療とホームモニタリング (第9版)」は、医療監視の無線ソリューション採用に関する直接的な洞察を提供している。モバイル産業はどのようにして無線医療監視に幅広いビジネスチャンスを見出せるだろうか。世界市場のセルラー接続による家庭用医療モニタリング機器数は、2017年末の1650万から6年間に年平均成長率(CAGR)38.7%で成長して2023年には8340万に達するだろうと予測している。300ページに及ぶ無線技術の医療機器へのシームレスな統合に関する詳細な調査レポートの第9版である。

目次(抜粋)

  • 慢性疾患に関する課題
  • モバイル医療のプラットフォーム
  • 生体機能のモニタリングソリューションプロバイダ
  • メディケーション、
    自動体外式除細動(AED)
    、統合モニタリングソリューションのプロバイダ
  • 市場分析と予測

Description

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of connected home medical monitoring devices on the global market was 16.5 million at the end of 2017 and is forecasted to grow at a CAGR of 31.0 percent in the next six years to reach 83.4 million in 2023. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 300 page in-depth report now in its ninth edition.

 


 

mHealth and Home Monitoring is the ninth consecutive report from Berg Insight that gives first-hand insights into the adoption of wireless solutions for health monitoring.

This strategic research report from Berg Insight provides you with 300 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

This report will allow you to:

  • Profit from 30 new executive interviews with market leading companies.
  • Learn about key home health monitoring devices and services.
  • Study the strategies of 130 key players in the mHealth ecosystem.
  • Understand the dynamics of the health monitoring market in Europe and North America.
  • Comprehend how wireless technology can become seamlessly integrated with medical devices.
  • Evaluate the business opportunities in the emerging mHealth segment.
  • Predict future market and technology developments.

 

16.5 million patients worldwide are remotely monitored

mHealth refers to the application of telecommunications in medicine and includes everything from connected medical devices to digital care programs. The adoption of mHealth solutions in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. The primary focus of this report is on home monitoring solutions, which are commonly used to manage patients with various chronic conditions such as cardiac arrhythmia, sleep apnoea and diabetes. Other applications include remote diagnostics, compliance monitoring and clinical trials.

The number of remotely monitored patients grew by 41 percent to 16.5 million in 2017 as the market acceptance continues to grow. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care
regimen. Berg Insight estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 31.0 percent to reach 83.4 million by 2023. Cellular connectivity remains the de-facto standard communication technology for most types of connected home medical monitoring devices and will account for 40.1 million connections in 2023. However, the use of patients’ own mobile devices as health hubs has become a viable alternative for remote patient monitoring and BYOD connectivity is already the preferred option in some segments. By 2023 a total of 40.3 million patients will rely on BYOD connectivity.

Berg Insight estimates that revenues for remote patient monitoring(RPM) solutions reached €13.9 billion in 2017, including revenues from medical monitoring devices, mHealth connectivity solutions, care delivery platforms and mHealth care programs. RPM revenues are expected to grow at a CAGR of 22.2 percent between 2017 and 2023 to reach € 46.1 billion at the end of the forecast period. Connected medical devices accounted for 68 percent of total RPM revenues in 2017. However, revenues for mHealth connectivity solutions, care delivery platforms and mHealth care programs are growing at a faster rate and will account for 59 percent of total revenues in 2023, up from just 32 percent in 2017.

There is a strong trend towards incorporating more connectivity in medical devices in order to enable new services and value propositions. Sleep therapy is by far the most connected segment and it is dominated by Philips and ResMed. The number of monitored patients has more than doubled since 2015, largely due to the compliance monitoring requirements that have been introduced in the US and France. Before, implantable cardiac rhythm management (CRM) has traditionally been the largest market segment, led by companies such as Medtronic, Biotronik and Abbott that included connectivity in CRM solutions more than a decade ago. Berg Insight predicts that three of the fastest growing market segments in the next six years will be glucose monitoring, airflow monitoring and connected medication solutions. Today, the leading connected healthcare players in these segments include forward-thinking incumbents as well as innovative new entrants such as Abbott, Adherium, Compliance Meds Technologies, Dexcom, Glooko, Medtronic, Merck Group, Novartis, Propeller Health, Roche, Senseonics, Voluntis and WellDoc.

Care delivery platforms and mHealth connectivity solutions are two of the most rapidly developing parts of the mHealth value chain. Care delivery platforms are software solutions that enable the remote delivery of healthcare services. There are various types of care delivery platforms available on the market. General-purpose platforms can be adapted to a wide variety of use cases and are often used as the basis for developing therapy-specific mHealth products. Companies that specialise in this area include BePatient, ERT, Medixine, S3 Connected Health, Tactio Health and Vivify Health. mHealth connectivity solutions include products and services that are used for collecting data from medical devices, transmitting this data to caregivers and enabling the data to be used by care delivery platforms. Important players include Qualcomm Life, eDevice, Apple, Microsoft, MedM and Validic.

Healthcare systems around the world are currently undergoing a major transformation. The adoption of value-based care is spreading, and healthcare providers are looking for new solutions to provide costefficient and improved care. In response to this, numerous companies are developing data-driven solutions to optimise healthcare. One example is the use of self-engagement apps that rely on behavioural analytics to coach patients in how to manage their conditions. Berg Insight believes that this transformation will spur the adoption of mHealth solutions and expects healthy growth in the mHealth industry in the next five years.

This report answers the following questions:

  • Which medical conditions offer the best potential for wireless health monitoring solutions?
  • Who are the leading providers of connected medical devices?
  • What are the mHealth strategies of medical device vendors and pharmaceutical companies?
  • Which are the general technology trends for home health monitoring equipment?
  • What initiatives have been taken by the leading players in the telecom and IT industries?
  • How can connectivity redefine the use cases of medical devices and the value propositions to patients and other stakeholders?
  • What are the market shares of the top 5 integrated telehealth solution vendors?
  • Why are smartphone applications so significant for the mHealth market?
  • How can healthcare providers and payers benefit from mHealth solutions?

Who should buy this report?

mHealth and Home Monitoring is the foremost source of information about the adoption of wireless solutions for health monitoring. Whether you are a medical equipment vendor, telecom operator, healthcare provider, investor, consultant, or government agency, you will gain valuable insights from our indepth research.



目次

Executive Summary

1 The challenge of chronic diseases
1.1 Introduction
1.1.1 The ageing world population
1.1.2 Lifestyle-related diseases
1.2 Common chronic diseases
1.2.1 Cardiac arrhythmia
1.2.2 Ischemic diseases
1.2.3 Hypertension
1.2.4 Sleep apnoea
1.2.5 Chronic respiratory diseases
1.2.6 Diabetes
1.2.7 Hyperlipidaemia
1.3 Healthcare providers and reimbursement systems
1.3.1 Healthcare in Asia-Pacific
1.3.2 Healthcare in Europe
1.3.3 Healthcare in North America
1.4 Regulatory environment
1.4.1 Regulatory environment in Europe
1.4.2 Regulatory environment in the US
1.4.3 Regulatory environment in other major markets
1.4.4 International standardisation

2 mHealth platforms
2.1 Overview of the mHealth market
2.1.1 mHealth market segments
2.1.2 Connectivity options for medical devices
2.1.3 The mHealth technology value chain
2.2 mHealth connectivity solutions
2.2.1 Alphabet
2.2.2 Apple
2.2.3 Ericsson
2.2.4 Deutsche Telekom
2.2.5 eDevice
2.2.6 KORE
2.2.7 MedM
2.2.8 Microsoft
2.2.9 Orange Healthcare
2.2.10 PTC
2.2.11 Qualcomm Life
2.2.12 Telenor Connexion
2.2.13 Vodafone
2.3 mHealth care delivery platforms
2.3.1 AT&T
2.3.2 Bepatient
2.3.3 Domicalis
2.3.4 ERT (Exco InTouch)
2.3.5 Get Real Health
2.3.6 Medixine
2.3.7 OpenTeleHealth
2.3.8 S3 Connected Health
2.3.9 Tactio Health
2.3.10 Verklizan

3 Physiological monitoring solution providers
3.1 Medical devices and remote monitoring
3.1.1 Medical device revenues by market segment
3.1.2 Overview of the remote patient monitoring market
3.2 Cardiac rhythm management
3.2.1 Overview of the CRM device market
3.2.2 Use cases for CRM monitoring
3.2.3 Remote monitoring solution providers
3.2.4 Abbott (St. Jude Medical)
3.2.5 Biotronik
3.2.6 Boston Scientific
3.2.7 Medtronic
3.2.8 MicroPort (LivaNova)
3.3 Remote ECG monitoring
3.3.1 Overview of the remote ECG monitoring device market
3.3.2 Use cases for remote ECG monitoring
3.3.3 Remote monitoring solution providers
3.3.4 Aerotel Medical Systems
3.3.5 AliveCor
3.3.6 BioTelemetry
3.3.7 CardioComm Solutions
3.3.8 GE Healthcare
3.3.9 iRhythm Technologies
3.3.10 LevMed
3.3.11 Preventice Solutions
3.3.12 ScottCare
3.3.13 TZ Medical
3.3.14 Zenicor
3.4 Blood pressure monitoring
3.4.1 Overview of the blood pressure monitoring device market
3.4.2 Use cases for blood pressure monitoring
3.4.3 Remote monitoring solution providers
3.4.4 A&D Medical
3.4.5 iHealth Labs
3.4.6 Microlife
3.4.7 Omron Healthcare
3.4.8 Rossmax
3.4.9 Welch-Allyn
3.5 Coagulation monitoring
3.5.1 Overview of the coagulation monitoring device market
3.5.2 Use cases for blood coagulation monitoring
3.5.3 Remote monitoring solution providers
3.5.4 CoaguSense
3.5.5 Helena Laboratories
3.5.6 iLine Microsystems
3.5.7 Instrumentation Laboratory (Accriva Diagnostics)
3.5.8 Roche Diagnostics
3.5.9 Siemens Healthineers
3.6 Sleep therapy monitoring
3.6.1 Overview of the sleep therapy device market
3.6.2 Use cases for sleep therapy monitoring
3.6.3 Remote monitoring solution providers
3.6.4 Fisher & Paykel Healthcare
3.6.5 Drive DeVilbiss Healthcare
3.6.6 Löwenstein Medical Technology
3.6.7 Philips Sleep and Respiratory Care
3.6.8 ResMed
3.6.9 SRETT
3.6.10 SomnoMed
3.7 Home sleep diagnostics
3.7.1 Overview of the home sleep diagnostics market
3.7.2 Use cases for home sleep diagnostics
3.7.3 Remote monitoring solution providers
3.7.4 Cadwell Laboratories
3.7.5 CleveMed
3.7.6 Compumedics
3.7.7 Infoscan
3.7.8 Natus Medical
3.7.9 NovaSom
3.7.10 Nox Medical
3.7.11 SleepMed
3.7.12 SOMNOmedics
3.8 Blood oxygen monitoring
3.8.1 Overview of the blood oxygen monitoring device market
3.8.2 Use cases for blood oxygen monitoring
3.8.3 Remote monitoring solution providers
3.8.4 ChoiceMMed
3.8.5 Masimo
3.8.6 Nonin Medical
3.9 Airflow monitoring
3.9.1 Overview of the air flow monitoring device market
3.9.2 Use cases for airflow monitoring
3.9.3 Remote monitoring solution providers
3.9.4 Adherium
3.9.5 AstraZeneca
3.9.6 Circassia Pharmaceuticals
3.9.7 Clement Clarke International
3.9.8 Medical International Research
3.9.9 Ndd Medizintechnik
3.9.10 nSpire Health
3.9.11 Propeller Health
3.9.12 Respiri
3.9.13 Sibelmed
3.9.14 Vitalograph
3.10 Glucose level monitoring
3.10.1 Overview of the glucose monitoring device market
3.10.2 Use cases for glucose monitoring
3.10.3 Remote monitoring solution providers
3.10.4 Abbott Diabetes Care
3.10.5 Ascensia Diabetes Care
3.10.6 BodyTel
3.10.7 Dexcom
3.10.8 Glooko
3.10.9 Insulet
3.10.10 Johnson & Johnson
3.10.11 Medtronic Diabetes Group
3.10.12 QuiO
3.10.13 Roche Diabetes Care
3.10.14 Senseonics
3.10.15 Telcare
3.10.16 Voluntis
3.10.17 WellDoc
3.11 Other
3.11.1 Implantable medical devices
3.11.2 Home hemodialysis
3.11.3 Telerehabilitation
3.11.4 Thermometers and weight scales
3.11.5 Mental health
3.11.6 Cholesterol monitoring

4 Medication, AED and integrated monitoring solution providers
4.1 Telehealth and multiparameter monitoring solutions
4.1.1 Overview of the telehealth solutions market
4.1.2 Use cases for telehealth solutions
4.1.3 Telehealth solution providers
4.1.4 Aeon Global Health
4.1.5 Care Innovations
4.1.6 H2AD
4.1.7 Ideal Life
4.1.8 LindaCare
4.1.9 Livongo Health
4.1.10 Medtronic Care Management Services
4.1.11 Medvivo
4.1.12 Optum
4.1.13 Philips Enterprise Telehealth
4.1.14 Resideo Technologies (Honeywell Life Care Solutions)
4.1.15 SHL Telemedicine
4.1.16 Telefónica
4.1.17 Tunstall Healthcare Group
4.1.18 Vitaphone
4.2 Medication compliance monitoring
4.2.1 Overview of the medication compliance monitoring market
4.2.2 Use cases for medication compliance monitoring
4.2.3 Compliance monitoring solution providers
4.2.4 AdhereTech
4.2.5 Compliance Meds Technologies
4.2.6 DayaMed
4.2.7 Evondos
4.2.8 InRange Systems
4.2.9 Medicpen
4.2.10 Merck Group
4.2.11 Philips Lifeline
4.2.12 Proteus Digital Health
4.3 Connected automated external defibrillators
4.3.1 Overview of the connected defibrillator market
4.3.2 Use cases for automated external defibrillators
4.3.3 Connected solutions providers
4.3.4 AEDMAP
4.3.5 Almas Industries
4.3.6 Cardia International
4.3.7 CardiLink
4.3.8 Laerdal Medical
4.3.9 Metrax
4.3.10 Nihon Kohden
4.3.11 Philips Patient Care and Monitoring Solutions
4.3.12 Physio-Control
4.3.13 Pyrescom
4.3.14 Schille
4.3.15 Zoll Medical Corporation

5 Market analysis and forecasts
5.1 Market forecasts
5.1.1 Cardiac rhythm management
5.1.2 Sleep therapy
5.1.3 Telehealth and multiparameter monitoring
5.1.4 ECG monitoring
5.1.5 Glucose level monitoring
5.1.6 Medication compliance monitoring
5.1.7 Other medical devices
5.2 Revenue forecasts
5.2.1 Medical monitoring devices
5.2.2 mHealth connectivity solutions
5.2.3 Care delivery platforms
5.2.4 mHealth care programs
5.3 Market drivers and barriers
5.3.1 An ageing population is raising medical costs
5.3.2 Obesity epidemic and increasing non-communicable disease prevalence
5.3.3 The generational technology barrier is disappearing
5.3.4 Alignment of financial incentives
5.3.5 Transformation to value-based care
5.3.6 Increased focus on disease prevention
5.3.7 Substitutes to medical monitoring
5.3.8 A slowly changing industry
5.3.9 Digitalisation of PSTN networks and decommission of 2G/3G networks
5.4 Industry trends and analysis
5.4.1 Consumerisation of medical-grade mHealth devices and apps
5.4.2 From frequent readings to AI-driven patient engagement
5.4.3 Major pharmaceutical companies prepare large-scale rollouts
5.4.4 BYOD is becoming a popular and viable option
5.4.5 The global adoption of telehealth is ramping up
5.4.6 Integrations are becoming crucial in the health data ecosystem
5.4.7 Compliance monitoring is a major driver behind home monitoring

Glossary

 

ページTOPに戻る

プレスリリース

[サマリー訳]

スウェーデンの調査会社ベルグインサイト社(Berg Insight)の調査レポート「モバイル医療とホームモニタリング (第9版)」は、医療監視の無線ソリューション採用に関する直接的な洞察を提供している。モバイル産業はどのようにして無線医療監視に幅広いビジネスチャンスを見出せるだろうか。世界市場のセルラー接続による家庭用医療モニタリング機器数は、2017年末の1650万から6年間に年平均成長率(CAGR)38.7%で成長して2023年には8340万に達するだろうと予測している。300ページに及ぶ無線技術の医療機器へのシームレスな統合に関する詳細な調査レポートの第9版である。

目次(抜粋)

  • 慢性疾患に関する課題
  • モバイル医療のプラットフォーム
  • 生体機能のモニタリングソリューションプロバイダ
  • メディケーション、
    自動体外式除細動(AED)
    、統合モニタリングソリューションのプロバイダ
  • 市場分析と予測

 

[サマリー原文]

mHealth and Home Monitoring is the ninth consecutive report from Berg Insight that gives first-hand insights into the adoption of wireless solutions for health monitoring.

This strategic research report from Berg Insight provides you with 300 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of connected home medical monitoring devices on the global market was 16.5 million at the end of 2017 and is forecasted to grow at a CAGR of 31.0 percent in the next six years to reach 83.4 million in 2023. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 300 page in-depth report now in its ninth edition.

 


 

[プレスリリース原文]

2018-12-17
Berg Insight says 16.5 million patients worldwide are remotely monitored

Berg Insight, the world’s leading M2M/IoT market research provider, today released new findings on the mHealth market. The number of remotely monitored patients grew by 41 percent to 16.5 million in 2017 as the market acceptance continues to grow in several key verticals. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Connected medical devices used for various forms of personal health tracking are not included in this figure. Berg Insight estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 31.0 percent to reach 83.4 million by 2023. The two main applications are monitoring of patients with sleep therapy devices and monitoring of patients with implantable cardiac rhythm management (CRM) devices.

These two segments accounted for 82 percent of all connected home medical monitoring systems in 2017. The number of remotely monitored sleep therapy patients grew by 37 percent in 2017, mainly driven by Philips and ResMed that together dominate the sleep therapy market. The CRM market is led by companies such as Medtronic, Boston Scientific and Abbott that started to include connectivity in CRM solutions more than a decade ago. Telehealth is the third largest segment with 0.8 million connections at the end of the year. Leading telehealth hub vendors include Tunstall Healthcare, Resideo (Honeywell), Medtronic, Philips and Qualcomm Life. Other device categories – including ECG, glucose level, medication compliance, blood pressure monitors and others – accounted for just over two million connections.

“The most promising segment is medication compliance, which we expect will become the second most connected segment in the next five years”, says Sebastian Hellström, IoT Analyst at Berg Insight. More than 60 percent of all connected medical monitoring devices rely on cellular connectivity today and has become the de-facto standard for most types of connected home medical monitoring devices. The number of mHealth devices with integrated cellular connectivity increased from 7.1 million in 2016 to 10.7 million in 2017. The use of BYOD connectivity will increase the most during the next six years, with a forecasted CAGR of 48.2 percent.

“BYOD involves low cost and the technology is mostly adopted in patient-centric therapeutic areas such as diabetes and asthma that have younger patient demographics compared to many other chronic diseases. Many of these patients prefer to use their own smartphone as the interface instead of carrying around a dedicated device for remote monitoring”, concluded Mr. Hellström.

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る